Compare TransMedics Group Inc (TMDX) vs Zillow Group Inc Class C (Z) Price & Performance

TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.

The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.

Zillow Group (Z) trades at $29.17, up 6.93% in the past 24 hours, showing strong momentum despite mixed technical signals. The company has demonstrated improving fundamentals with revenue growing from $2.2B in 2024 to $2.6B in 2025, and net income turning positive at $23M after a $112M loss the prior year. Recent earnings show two consecutive beats, with Q2 2026 EPS of $0.52 exceeding expectations of $0.4459. Analyst consensus remains divided with a $60.33 price target representing significant upside potential from current levels.

The outlook for Zillow appears cautiously optimistic with improving profitability and strategic AI integration, though the stock faces headwinds from high mortgage rates and housing market volatility. The company's transition to an integrated transaction platform shows promise, but execution risks remain amid competitive pressures and regulatory scrutiny. With a P/E ratio of 126.83 indicating premium valuation, investors should monitor housing market trends and the company's ability to sustain recent earnings momentum.